Prior authorization reform: A hybrid approach of regulatory requirements and voluntary commitments | McDermott+
McDermott+ is pleased to bring you Regs & Eggs, a weekly Regulatory Affairs blog by Jeffrey Davis. May 14, 2026…
Blog
McDermott+ is pleased to bring you Regs & Eggs, a weekly Regulatory Affairs blog by Jeffrey Davis. May 14, 2026…
Pharmacy Benefit Manager (“PBM”) arrangements have long relied on rebates with limited transparency into true drug costs. Recent regulatory and…
Executive Summary What’s new: On 29 April 2026, the PRA released Consultation Paper CP8/26, proposing a fundamental recalibration of the…
Florida rate cuts highlight litigation’s role in insurance affordability Wilson has framed tort reform as part of a broader affordability…
Health insurance is expensive and can be difficult to afford for people with lower or moderate incomes. In response, the…